KURE:NYE-KraneShares MSCI All China Health Care Index ETF (USD)

ETF | China Region |

Last Closing

USD 14.475

Change

+0.15 (+1.01)%

Market Cap

USD 0.04B

Volume

2.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for China Region

Symbol Name Price(Change) Market Cap
KWEB KraneShares CSI China Internet..

+0.05 (+0.17%)

USD 5.86B
CQQQ Invesco China Technology ETF

+0.07 (+0.17%)

USD 0.70B
GXC SPDR® S&P China ETF

+0.68 (+0.89%)

USD 0.41B
FLTW Franklin FTSE Taiwan ETF

-0.10 (-0.21%)

USD 0.38B
CHIQ Global X MSCI China Consumer D..

+0.21 (+1.06%)

USD 0.22B
KBA KraneShares Bosera MSCI China ..

+0.37 (+1.57%)

USD 0.18B
FLCH Franklin FTSE China ETF

+0.17 (+0.88%)

USD 0.15B
ECNS iShares MSCI China Small-Cap E..

+0.22 (+0.86%)

USD 0.06B
KGRN KraneShares MSCI China Clean T..

+0.35 (+1.53%)

USD 0.05B
ASHS Xtrackers Harvest CSI 500 Chin..

+0.31 (+1.08%)

USD 0.04B

ETFs Containing KURE

KGRO 23.62 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (China Region) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.24% 11% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.24% 6% D- 12% F
Trailing 12 Months  
Capital Gain -13.40% 11% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.40% 6% D- 14% F
Trailing 5 Years  
Capital Gain -37.27% 17% F 15% F
Dividend Return 18.35% 83% B 60% D-
Total Return -18.92% 28% F 17% F
Average Annual (5 Year Horizon)  
Capital Gain -10.32% 17% F 6% D-
Dividend Return -10.19% 11% F 5% F
Total Return 0.14% 6% D- 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 33.74% 39% F 31% F
Risk Adjusted Return -30.19% 17% F 8% B-
Market Capitalization 0.04B 23% F 17% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.